Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07730567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 28, 2026 (before its estimated September 13, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
To evaluate the pharmacokinetic interaction and the safety of AD-236A and AD-236B in healthy adult volunteers
Trial Details
NCT Number NCT07730567
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Hyperlipidemia, Diabete Type 2
Related terms Diabetes Mellitus, Type 2, Hyperlipidemias
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov